Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Congenital chylothorax treated with oral sildenafil: a case report and review of the literature

Journal of Perinatology volume 35, pages 384–386 (2015)Cite this article

Subjects

Abstract

Congenital chylothorax (CC) can result from a congenital malformation or an acquired obstruction or disruption of the thoracic duct. Recently, oral administration of the phosphodiesterase-5 inhibitor, sildenafil, was reported to be effective in resolving non-pulmonary lymphatic malformations in infants and young children. We report a case of CC in a late preterm infant with congenital pulmonary lymphangiectasia where octreotide was not effective, but management with oral sildenafil was successful.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Rocha G, Fernandes P, Rocha P, Quintas C, Martins T, Proenca E . Pleural effusions in the neonate. Acta Paediatr 2006; 95: 791–798.

    Article  Google Scholar 

  2. Downie L, Sasi A, Malhotra A . Congenital chylothorax: associations and neonatal outcomes. Journal of paediatrics and child health 2014; 50: 234–238.

    Article  Google Scholar 

  3. Danial C, Tichy AL, Tariq U, Swetman GL, Khuu P, Leung TH et al. An open- label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol 2014; 70: 1050–1057.

    Article  CAS  Google Scholar 

  4. Swetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL . Sildenafil for severe lymphatic malformations. N Engl J Med 2012; 366: 384–386.

    Article  CAS  Google Scholar 

  5. Iacovidou N, Syggelou A, Fanos V, Xanthos T . The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature. Curr Pharm Des 2012; 18: 3034–3045.

    Article  CAS  Google Scholar 

  6. Reiterer F, Grossauer K, Morris N, Uhrig S, Resch B . Congenital pulmonary lymphangiectasis. Paediatr Respir Rev 2014; 15: 275–280.

    PubMed  Google Scholar 

  7. Battaglia A . The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis 2008; 3: 30.

    Article  Google Scholar 

  8. Bellini C, Mazzella M, Campisi C, Taddei G, Mosca F, Toma P et al. Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax- hydrops fetalis continuum. Lymphology 2004; 37: 22–30.

    CAS  PubMed  Google Scholar 

  9. Ozeki M, Kanda K, Kawamoto N, Ohnishi H, Fujino A, Hirayama M et al. Propranolol as an alternative treatment option for pediatric lymphatic malformation. Tohoku J Expe Med 2013; 229: 61–66.

    Article  CAS  Google Scholar 

  10. Poralla C, Specht S, Born M, Muller A, Bartmann P, Muller A . Treatment of congenital generalized lymphangiectasia with propranolol in a preterm infant. Pediatrics 2014; 133: e439–e442.

    Article  Google Scholar 

  11. Reinglas J, Ramphal R, Bromwich M . The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 2011; 121: 1851–1854.

    PubMed  Google Scholar 

  12. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova M et al. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 2011; 117: 4667–4678.

    Article  CAS  Google Scholar 

  13. Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, Wang YJ et al. Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. Arthritis Rheum 2011; 63: 2318–2328.

    Article  CAS  Google Scholar 

  14. Kajiya K, Huggenberger R, Drinnenberg I, Ma B, Detmar M . Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase alpha1beta1-impact on inflammation. FASEB J 2008; 22: 530–537.

    Article  CAS  Google Scholar 

  15. Jeon YH, Heo YS, Kim CM, Hyun YL, Lee TG, Ro S et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci 2005; 62: 1198–1220.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA

    D T Malleske & B A Yoder

Authors
  1. D T Malleske
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B A Yoder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D T Malleske.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malleske, D., Yoder, B. Congenital chylothorax treated with oral sildenafil: a case report and review of the literature. J Perinatol 35, 384–386 (2015). https://doi.org/10.1038/jp.2015.10

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2015.10

This article is cited by

Search

Advanced search

Quick links